(Program is subject to changes)

Plenary Speakers

• J. Biederman (Topic TBA)
• The Many Aspects of COVID-19 and What did we Learn from It? I. Manor
• Conceptualizing ADHD as Neurodiversity: How does it Change ADHD Science? – E. Sonuga-Barke
• New Insights on ADHD Trajectories Across the Life Cycle? – L. Rohde
• ADHD as a Systems Disease – J. Buitelaar
• Symptoms and EF in Youth at the Community – M. Weiss

Partial List of Symposia

• ADHD and Preschoolers
• Adult ADHD and CBT as a Treatment: College Student
• From a Difficult Child to a Complex Patient: Coping with Adult ADHD Patient in Primary Care. The Role of the GP and How to Accomplish It?
• Treating ADHD Parent-child Dyads
• Presenting a Case of an Adult with ADHD and Comorbid Ehlers Danlos Syndrome (Hypermobility Syndrome) and Suspected Mast Cell Activation Syndrome – Assessment Insights and Management Implications
• The Many Aspects of COVID-19 Influence on ADHD
• Genetics and Diagnostics

• ADHD and Inflammation Processes

• Medical Comorbidities:  AHDH in Chronically ill Patients

• Dysregulation Disorders
• New Medications and Treatments

• Specific Populations

Panel

Education of ADHD in Different Countries and the Struggle with Disinformation and the Media

Debate

Should Psychiatry Merge with Neurology?